Table 3.
Strains | Agent | MIC/MBC (μg/mL) | FIC | FICI2 | Outcome | |
---|---|---|---|---|---|---|
Alone | Combination1 | |||||
S. mutans ATCC 251753 | Silibinin | 0.2/0.4 | 0.05/0.1 | 0.25/0.25 | 0.5/0.5 | Synergistic/synergistic |
Gentamicin | 8/16 | 2/4 | 0.25/0.25 | |||
S. sanguinis ATCC 10556 | Silibinin | 0.4/0.4 | 0.1/0.2 | 0.25/0.5 | 0.375/0.75 | Synergistic/additive |
Gentamicin | 64/64 | 8/16 | 0.125/0.25 | |||
S. sobrinus ATCC 27607 | Silibinin | 0.4/0.8 | 0.05/0.2 | 0.125/0.25 | 0.375/0.5 | Synergistic/synergistic |
Gentamicin | 4/8 | 1/2 | 0.25/0.25 | |||
S. ratti KCTC 32944 | Silibinin | 0.8/0.8 | 0.2/0.4 | 0.25/0.5 | 0.5/0.625 | Synergistic/additive |
Gentamicin | 16/32 | 4/4 | 0.25/0.125 | |||
S. criceti KCTC 3292 | Silibinin | 0.8/1.6 | 0.2/0.4 | 0.25/0.25 | 0.375/0.375 | Synergistic/synergistic |
Gentamicin | 8/16 | 1/2 | 0.125/0.125 | |||
S. anginosus ATCC 31412 | Silibinin | 0.8/1.6 | 0.2/0.2 | 0.25/0.125 | 0.375/0.375 | Synergistic/synergistic |
Gentamicin | 32/32 | 4/8 | 0.125/0.25 | |||
S. gordonii ATCC 10558 | Silibinin | 0.1/0.2 | 0.025/0.05 | 0.25/0.25 | 0.375/0.5 | Synergistic/synergistic |
Gentamicin | 32/32 | 4/8 | 0.125/0.25 | |||
A. actinomycetemcomitans ATCC 43717 | Silibinin | 1.6/3.2 | 0.4/0.8 | 0.25/0.25 | 0.5/0.5 | Synergistic/synergistic |
Gentamicin | 4/8 | 1/2 | 0.25/0.25 | |||
F. nucleatum ATCC 51190 | Silibinin | 3.2/6.4 | 0.8/1.6 | 0.25/0.25 | 0.5/0.5 | Synergistic/synergistic |
Gentamicin | 2/4 | 0.5/1 | 0.25/0.25 | |||
P. intermedia ATCC 25611 | Silibinin | 1.6/3.2 | 0.4/0.8 | 0.25/0.25 | 0.5/0.375 | Synergistic/synergistic |
Gentamicin | 16/32 | 4/4 | 0.25/0.125 | |||
P. gingivalis ATCC 33277 | Silibinin | 0.8/0.8 | 0.1/0.2 | 0.125/0.25 | 0.375/0.375 | Synergistic/synergistic |
Gentamicin | 256/512 | 64/64 | 0.25/0.125 |
1The MIC and MBC of the silibinin with gentamicin.
2The fractional inhibitory concentration index (FIC index).
3American Type Culture Collection (ATCC).
4Korean collection for type cultures (KCTC).